Evaluating the performance of four anti-dsDNA antibody detection methods
- 23 August 2025
- journal article
- Published by SAGE Publications in Lupus
Abstract
Objective: To evaluate the concordance of four anti-dsDNA antibody detection methods—Crithidia luciliae indirect immunofluorescence test (CLIFT), enzyme-linked immunosorbent assay (ELISA), acridine ester direct chemiluminescence immunoassay (CLIA), and digital liquid chip method (DLCM)—and to assess their diagnostic efficacy in systemic lupus erythematosus (SLE) patients. Methods: A total of 285 serum samples were collected, including 170 SLE patients, 39 with non-SLE autoimmune diseases (AIDs), 28 with non-AIDs, and 48 undiagnosed cases. The concordance and diagnostic performance of anti-dsDNA antibody methods were analyzed. Results: The diagnostic performance showed that DLCM exhibited the highest sensitivity (86.87%), while CLIA demonstrated the highest specificity (94.03%). The area under the receiver operating characteristic (ROC) curve (AUC) was ranked as CLIFT < ELISA < CLIA < DLCM (AUC = 0.938). Anti-dsDNA antibodies detected by both CLIFT and DLCM correlated well with the SLE disease activity index (SLEDAI), while CLIFT and CLIA were significantly correlated with lupus nephritis. Utilizing ROC curve-derived cut-off values, the overall concordance of CLIFT and other methods ranged from 80.14% to 82.58% (kappa > 0.6, P < 0.001), and the concordance between quantitative methods ranged from 89.55% to 91.29% (kappa > 0.8, P < 0.001). Conclusion: CLIFT, ELISA, CLIA, and DLCM all showed impressive diagnostic efficacy in detecting anti-dsDNA antibodies. CLIFT shows a strong correlation with SLE activity and lupus nephritis. DLCM, a relatively new method, also showed excellent performance and could be integrated into clinical laboratory workflows for anti-dsDNA antibody testing.Keywords
Funding Information
- Natural Science Foundation of Sichuan Province (2024YFFK0222)
- National Key R&D Program of China (2022YFC2406600/2022YFC2406604)
This publication has 30 references indexed in Scilit:
- KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITISKidney International, 2024
- Autoantibodies to dsDNA in the diagnosis, classification and follow-up of patients with systemic lupus erythematosusJournal of Translational Autoimmunity, 2023
- Laboratory evaluation of anti-dsDNA antibodiesClinica Chimica Acta, 2022
- Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysisAutoimmunity Reviews, 2019
- The clinical utility of anti-double-stranded DNA antibodies and the challenges of their determinationJournal of Immunological Methods, 2018
- The performance of different anti-dsDNA autoantibodies assays in Chinese systemic lupus erythematosus patientsClinical Rheumatology, 2017
- Flow-Induced Dispersion Analysis for Probing Anti-dsDNA Antibody Binding Heterogeneity in Systemic Lupus Erythematosus Patients: Toward a New Approach for Diagnosis and Patient StratificationAnalytical Chemistry, 2016
- Anti-dsDNA antibodies in systemic lupus erythematosus: A combination of two quantitative methods and the ANA pattern is the most efficient strategy of detectionJournal of Immunological Methods, 2015
- Anti-DNA antibodies — quintessential biomarkers of SLENature Reviews Rheumatology, 2015
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982